Grain Processing Corporation has opened a large, high quality, and efficient distillery capable of meeting demand for ethyl alcohol for the manufacture of essential products such as hand sanitizers, disinfectants, mouthwash, and cough & cold medicines.
Grain Processing Corporation (GPC; Muscatine, IA), a member of the Kent Corporation family of companies, has opened a large, high quality, and efficient distillery capable of meeting demand for ethyl alcohol for the manufacture of essential products such as hand sanitizers, disinfectants, mouthwash, cough & cold medicines, as well as active pharma ingredients, vaccine components and Covid-19 testing reagents.
“To produce alcohol to 1 ppm or less total impurities, there are no short cuts,” said Pat Homoelle, president of GPC, in a press release. “Our world-class quality sets us apart and is recognized by our trusted partners who depend upon us to consistently craft gallon after gallon for a range of products from beverage alcohol to pharmaceutical-grade applications.”
The new distillery is the result of a multi-year, multi-million-dollar capital investment, originally announced in 2015. When construction began, the COVID-19 pandemic significantly increased the demand for high purity alcohol, and the project’s timeline was compressed to nearly eight months. The original startup date was July 2021.
“The accelerated completion of the distillery during the pandemic will go down as one of Kent Corporation’s greatest success stories during very challenging circumstances,” said Homoelle.
GPC credits the successful completion of the distillery to the dedication, expertise, and flexibility of its team. The accelerated timeline required additional contract labor and overtime hours, fast-track on equipment and material deliveries, as well as considerable project management and contractor oversite by multiple engineers.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.